Phase III study shows Tecentriq and Avastin plus chemo reduced risk of disease progression or death in advanced lung cancer December 07, 2017Vol.40 No.10
Mount Sinai researchers develop first mathematical model for predicting patient response to immunotherapy December 07, 2017Vol.40 No.10
Drugs & Targets FDA approves Kite’s CAR-T cell therapy; another win for NCI’s intramural program November 07, 2017Vol.40 No.09By Matthew Bin Han Ong
Pfizer, Astellas report positive results from trial of Xtandi in non-metastatic castration-resistant disease November 07, 2017Vol.40 No.09
Cleveland Clinic study: timing of melanoma diagnosis, treatment critical to survival November 07, 2017Vol.40 No.09
Local radiation provides comparable control of brain metastases compared to surgery November 07, 2017Vol.40 No.09
Trastuzumab for HER-2-expressing tumors needn’t delay breast reconstruction November 07, 2017Vol.40 No.09
